# Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke

> **NCT00630396** · PHASE1,PHASE2 · COMPLETED · sponsor: **David Hess, MD** · enrollment: 60 (actual)

## Conditions studied

- Stroke, Acute

## Interventions

- **DRUG:** Minocycline

## Key facts

- **NCT ID:** NCT00630396
- **Lead sponsor:** David Hess, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2012-01-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00630396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00630396, "Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00630396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*